Healixia is the Belgian community of all professionals active along the life cycle of medicines, medical devices, in vitro diagnostics & other health related products. Members are active in research & development (including pre-clinical, early clinical and later phases), medical affairs, safety, regulatory affairs and market access in industry, academia, investigator sites, authorities, regulatory bodies or in consultancy.
Healixia provides education, training and networking opportunities within and across each of the 4 domains it represents.
Healixia events
-
05 November '24Healixia Essentials webinar: The role of KCE and KCE Trials in the Belgian healthcare landscape
OnlineRead moreCome hear all about the KCE and KCE trials, presented by Frank Hulstaert, MD, MSc - senior researcher at KCE.
-
14 November '24Healixia Regulatory session on ATMP's
GrimbergenRead moreWith speakers from FAMHP on regulatory, clinical & quality aspects of ATMP's.
-
21 November '24Healixia webinar on case law within the pharmaceutical sector
Read moreFree 60 minutes webinar.
During the upcoming session at Healixia, we will delve into recent developments in case law within the pharmaceutical sector, focusing on significant rulings from both Belgian courts and the European Court of Justice (ECJ). This session aims to provide attendees with a comprehensive understanding of how recent judgments impact the pharmaceutical industry, including regulatory changes, intellectual property rights, and market access. Through analysis and discussion, participants will gain insights into the evolving legal landscape and its implications for businesses operating in this sector.
